Skip to main content
Displaying 1 - 12 of 12
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion and Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
NASH: a growing unmet therapeutic need
Webcasts
View
Metabolism, Alcohol & Toxicity
The underestimated role of thyroid hormone pathway in the pathophysiology of NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Key take home messages and close
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?
Webcasts
View
Metabolism, Alcohol & Toxicity
Live discussion
Webcasts
View
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH
Webcasts
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy